Telehealth allowed patients to stay in treatment for opioid use disorder during pandemic

The expansion of telehealth services during the COVID-19 pandemic allowed patients to remain in treatment for opioid use disorder, according to findings published in the Journal of Rural Mental Health.
“Opioid use disorder is intertwined with many infectious disease syndromes, including skin and soft tissue infection, osteomyelitis, endocarditis, hepatitis C, hepatitis B and HIV, which occur as collateral damage in these patients, leading to increased costs of care across the spectrum,” Raghavendra Tirupathi, MD, FACP, FIDSA, FRCP, an infectious disease physician at Keystone

The expansion of telehealth services during the COVID-19 pandemic allowed patients to remain in treatment for opioid use disorder, according to findings published in the Journal of Rural Mental Health.
“Opioid use disorder is intertwined with many infectious disease syndromes, including skin and soft tissue infection, osteomyelitis, endocarditis, hepatitis C, hepatitis B and HIV, which occur as collateral damage in these patients, leading to increased costs of care across the spectrum,” Raghavendra Tirupathi, MD, FACP, FIDSA, FRCP, an infectious disease physician at Keystone